earnings
confidence high
sentiment neutral
materiality 0.60
Dentsply Sirona Q2 2026: net sales $898M (-4.1% YoY), adj EPS $0.52 flat
DENTSPLY SIRONA Inc.
2026-Q2 EPS
reported $0.14
vs consensus $0.36
▼ miss
(-60.7%)
- Net sales $898M, down 4.1% YoY; GAAP diluted EPS $0.18 vs. ($0.22) loss in Q2 2025.
- Adjusted EPS $0.52 (flat YoY); adjusted gross margin 56.4%, adjusted EBITDA margin 21.3% (vs. 21.1%).
- Reiterates FY2026 outlook: net sales $3.5-3.6B, adjusted EPS $1.40-1.50; tariff refunds excluded.
- Repurchased 1.3M shares (~$12M); operating cash flow $99M vs. $48M, including ~$44M tariff refunds.
- Expanded Medline Sinclair partnership for Connected Technology Solutions portfolio across Canada.